Scinai Immunotherapeutics Ltd ADR (SCNI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 14,608 | 10,172 | 15,844 | 20,589 | 21,789 |
| Marketable Securities | N/A | N/A | N/A | N/A | 340 |
| Receivables | 749 | 1,114 | 847 | 1,131 | 1,071 |
| TOTAL | $15,357 | $11,286 | $16,691 | $21,720 | $23,200 |
| Non-Current Assets | |||||
| PPE Net | 6,665 | 5,149 | 3,568 | 1,589 | 371 |
| Other Non-Current Assets | 245 | 241 | 250 | 254 | 146 |
| TOTAL | $6,910 | $5,390 | $3,818 | $1,843 | $517 |
| Total Assets | $22,267 | $16,676 | $20,509 | $23,563 | $23,717 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 747 | 577 | 2,645 | 1,985 | 890 |
| TOTAL | $747 | $577 | $2,645 | $1,985 | $890 |
| Non-Current Liabilities | |||||
| Long Term Debt | 11,792 | 5,674 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 5,726 | 5,848 | 5,875 | 5,353 | 3,375 |
| TOTAL | $17,518 | $11,522 | $5,875 | $5,353 | $3,375 |
| Total Liabilities | $18,265 | $12,099 | $8,520 | $7,338 | $4,265 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | N/A | N/A | 65 | N/A |
| Retained earnings | -45,590 | -44,688 | -39,163 | -35,598 | -31,473 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | 151 |
| TOTAL | $4,002 | $4,577 | $11,989 | $16,225 | $19,452 |
| Total Liabilities And Equity | $22,267 | $16,676 | $20,509 | $23,563 | $23,717 |